We are live on ! Find out more
WCBA

Weaver C. Barksdale & Associates Portfolio holdings

AUM $105M
1-Year Est. Return 13.81%
This Fund
S&P 500
This Quarter Est. Return
-1.4%
1 Year Est. Return
+13.81%
3 Year Est. Return
+40.08%
5 Year Est. Return
10 Year Est. Return
AUM
$107M
AUM Growth
-$6.45M
Cap. Flow
-$3.31M
Cap. Flow %
-3.09%
Top 10 Hldgs %
20.92%
Holding
63
New
1
Increased
5
Reduced
55
Closed
1

Top Sells

Rank Stock Value
1
DGX icon
Quest Diagnostics
DGX
+$2.27M
2
MRK icon
Merck
MRK
+$119K
3
AMP icon
Ameriprise Financial
AMP
+$117K
4
NXST icon
Nexstar Media Group
NXST
+$114K
5
UL icon
Unilever
UL
+$106K

Sector Composition

Rank Sector Weight
1 Financials 19.82%
2 Healthcare 15.66%
3 Industrials 11.14%
4 Energy 9.77%
5 Technology 9.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PKG icon
26
Packaging Corp of America
PKG
$22.9B
$1.89M 1.77%
13,648
-656
-5% -$89.2K
EOG icon
27
EOG Resources
EOG
$75.1B
$1.89M 1.76%
16,472
-813
-5% -$98.6K
CSCO icon
28
Cisco
CSCO
$475B
$1.87M 1.74%
35,708
-1,703
-5% -$83.2K
UPS icon
29
United Parcel Service
UPS
$88.5B
$1.86M 1.74%
9,578
-460
-5% -$84.4K
GD icon
30
General Dynamics
GD
$107B
$1.85M 1.73%
8,121
-392
-5% -$90.6K
MET icon
31
MetLife
MET
$61.6B
$1.83M 1.71%
31,581
-1,518
-5% -$102K
BMY icon
32
Bristol-Myers Squibb
BMY
$130B
$1.82M 1.7%
26,204
+3,252
+14% +$229K
CCI icon
33
Crown Castle
CCI
$31.4B
$1.81M 1.69%
13,494
-661
-5% -$91.4K
SCHW
34
Charles Schwab
SCHW
$187B
$1.8M 1.69%
34,444
+7,140
+26% +$523K
PFG icon
35
Principal Financial Group
PFG
$24.3B
$1.79M 1.67%
24,111
-1,178
-5% -$99.9K
KR icon
36
Kroger
KR
$34.3B
$1.77M 1.65%
35,859
-1,736
-5% -$79.4K
CMI icon
37
Cummins
CMI
$87.4B
$1.76M 1.64%
7,353
-358
-5% -$87.4K
AES icon
38
AES
AES
$10.5B
$1.71M 1.6%
70,968
-3,445
-5% -$87.6K
TD icon
39
Toronto Dominion Bank
TD
$201B
$1.7M 1.59%
28,402
-1,369
-5% -$88.5K
JNJ icon
40
Johnson & Johnson
JNJ
$625B
$1.67M 1.56%
10,776
+1,596
+17% +$258K
CMCSA icon
41
Comcast
CMCSA
$90.6B
$1.63M 1.52%
42,922
-1,732
-4% -$65.5K
BEN icon
42
Franklin Resources
BEN
$17B
$1.57M 1.47%
58,288
-2,853
-5% -$83.3K
ENB icon
43
Enbridge
ENB
$114B
$1.56M 1.46%
41,010
-2,009
-5% -$78.8K
PRU icon
44
Prudential Financial
PRU
$42.3B
$1.55M 1.45%
18,756
-909
-5% -$86.8K
JPM icon
45
JPMorgan Chase
JPM
$964B
$1.53M 1.43%
11,713
-585
-5% -$80.2K
UGI icon
46
UGI
UGI
$7.48B
$1.52M 1.42%
43,660
-2,089
-5% -$79.2K
CVS icon
47
CVS Health
CVS
$120B
$1.48M 1.38%
19,899
-944
-5% -$79.2K
BBY icon
48
Best Buy
BBY
$17.6B
$1.46M 1.36%
18,599
-764
-4% -$62.9K
PFE icon
49
Pfizer
PFE
$152B
$1.45M 1.36%
35,537
-1,885
-5% -$81.4K
EMN icon
50
Eastman Chemical
EMN
$8.53B
$1.44M 1.34%
17,040
-817
-5% -$70.2K

Similar funds

Weaver C. Barksdale & Associates's Q1 2023 Portfolio in Review

As of Q1 2023, Weaver C. Barksdale & Associates held 63 positions worth $107M, down 5.7% from $113M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Weaver C. Barksdale & Associates withdrew a net $3.31M in Q1 2023, closing 1 position and reducing 55 holdings. Its most notable exit was Quest Diagnostics, an estimated $2.27M position sold in full.

By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Weaver C. Barksdale & Associates opened a new position in LyondellBasell Industries worth $1.98M.

  • Weaver C. Barksdale & Associates's largest Q1 2023 buy was LyondellBasell Industries: 21,044 shares worth $1.98M.
  • Weaver C. Barksdale & Associates added most to Charles Schwab in Q1 2023, an estimated $523K increase.
  • Weaver C. Barksdale & Associates's biggest Q1 2023 reduction was Merck, cutting an estimated $119K.
  • Weaver C. Barksdale & Associates fully exited Quest Diagnostics in Q1 2023, selling an estimated $2.27M.
  • Weaver C. Barksdale & Associates's ten largest holdings make up 21% of its $107M portfolio in Q1 2023.
  • Weaver C. Barksdale & Associates opened 1 new position and closed 1 in Q1 2023.
  • Weaver C. Barksdale & Associates's portfolio value fell 5.7% quarter-over-quarter to $107M.

Based on Weaver C. Barksdale & Associates's 13F filing for Q1 2023, filed 12 May 2023.